The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics (Version 1 23Aug2018)
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2019
At a glance
- Drugs GSK 2321138A (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms FLU2
- 08 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Nov 2018 Status changed from not yet recruiting to recruiting.
- 03 Oct 2018 New trial record